Lizzy Smyth/oncology-forum.co.uk
Sep 18, 2024, 22:54
Lizzy Smyth: Radiotherapy does not add to mFOLFIRINOX in borderline resectable Pancreatic Cancer
Lizzy Smyth, Consultant Medical Oncologist in upper GI oncology at Oxford University NHS Foundation Trust, shared a post on X:
“Radiotherapy does not add to mFOLFIRINOX in borderline resectable Pancreatic Cancer – results for PRODIGE-44.
Good news for patients with PDAC – mFOLFIRINOX had outcomes (mOS 32.8m, 47.9m OS if resected).
Results confirm ESMO guidelines recommendations.”
Sunnie Kim, GI Medical Oncologist at University of Colorado Cancer Center, shared this post, adding:
“Pancreatic cancer is a systemic disease unless proven otherwise!”
Sources: Lizzy Smyth/X and Sunnie Kim/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 17:14
Nov 14, 2024, 16:29
Nov 14, 2024, 16:27
Nov 14, 2024, 16:22
Nov 14, 2024, 16:22
Nov 14, 2024, 16:13
Nov 14, 2024, 16:03